On June 13, 2024, we entered into an agreement with a third party for the lease of office space in Tel Aviv, Israel for our principal

filing / Jan 20, 2026 / receipt

We consider that our current office space is sufficient to meet our anticipated needs for the foreseeable future and is suitable for the conduct of our business.

filing / Jan 20, 2026 / receipt

The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain

filing / Jan 20, 2026 / receipt

International expansion of our business exposes us to business, regulatory, political, operational, financial and economic risks associated with doing business outside of the United States, Canada or Israel.

filing / Jan 20, 2026 / receipt

and elsewhere is cost containment. Government authorities and third-party payors have attempted to control costs by limiting coverage

filing / Jan 20, 2026 / receipt

our future international expansion and operations and, consequently, our results of operations. 56 Certain of our directors and officers may have interests that compete with ours.

filing / Jan 20, 2026 / receipt

Dr. Adi Zuloff-Shani | 59 | Chief Executive Officer

filing / Jan 20, 2026 / receipt

Alan Rootenberg | 74 | Chief Financial Officer

filing / Jan 20, 2026 / receipt

Prof. Mark Haden | 73 | Vice President of Business Development

filing / Jan 20, 2026 / receipt

Hila Kiron-Revach | 46 | Director

filing / Jan 20, 2026 / receipt